🇪🇺 Modified release hydrocortisone in European Union

EMA authorised Modified release hydrocortisone on 3 November 2011

Marketing authorisation

EMA — authorised 3 November 2011

  • Application: EMEA/H/C/002185
  • Marketing authorisation holder: Takeda Pharmaceuticals International AG Ireland Branch
  • Local brand name: Plenadren
  • Indication: Treatment of adrenal insufficiency in adults.
  • Status: approved

Read official source →

Other Endocrinology approved in European Union

Frequently asked questions

Is Modified release hydrocortisone approved in European Union?

Yes. EMA authorised it on 3 November 2011.

Who is the marketing authorisation holder for Modified release hydrocortisone in European Union?

Takeda Pharmaceuticals International AG Ireland Branch holds the EU marketing authorisation.